Last week Neola Medical announced its partnership with the international digital network for neonatologists, 99NICU. The partnership initiates the market preparations before the launch of Neola™, the company’s medical device for continuous lung monitoring. In 99NICU’s new series “NEOvations”, a series of webinars focusing on new technology within neonatology, Neola Medical will present its product, Neola™, February 14 at 4pm (CET, 16.00). The Italian neonatologist MD Ph.D Gianluca Lista is also invited as keynote speaker, to talk about how the care of preterm born infants can be improved by non-invasive lung monitoring.
The market preparations before the launch of Neola™, Neonatal Lung Analyzer, has been initiated through a partnership with the international network 99NICU and the new webinar series “NEOvations”. 99NICU an internet-based neonatology network founded by staff from Karolinska University Hospital in Stockholm. It was founded as a platform for sharing experiences and expertise, regardless of location and time zone. The network’s new webinar series, NEOvations, aims to provide both insights into new innovations within neonatal care and to open possibilities to share knowledge and experiences.
Neola Medical is a partner to NEOvations, and February 14 at 4pm (CET, 16.00) the company will present Neola™, for continuous and non-invasive lung monitoring. The Italian neonatologist MD Ph.D Gianluca Lista is also invited to the webinar to talk more about how the care of preterm born infants can be improved by non-invasive monitoring. MD Ph.D. Gianluca Lista has a vast experience and has published more than 100 papers in international peer reviewed journals. He focuses on experimental and clinical research of the preterm, brain and lung, during fetal neonatal transition and in the Neonatal Intensive Care Unit (NICU) and he is currently Chief at the neonatology departement at Ospedale dei Bambini Vittori Buzzi in Milan.
Read earlier press release about the market preparations and 99NICU here: Press communication